FDA Approves Unknown Drug — ASPEN

# FDA Approves ASPEN's New Drug Application The FDA approved ASPEN's new drug application (NDA020992) on March 24, 1999, expanding the pharmaceutical manufacturer's product portfolio and positioning the company to capture additional market share in its therapeutic category. The approval strengthens ASPEN's competitive standing and opens new revenue opportunities as the company brings the newly authorized treatment to healthcare providers and patients.